The chemokines CCL22 and CCL17 are a defining feature of type 2 stimulated human lung macrophages and exhibit different metabolic dependencies Article Swipe
Amanda J. L. Ridley
,
Annabel J. Curle
,
Stefano A. P. Colombo
,
Jane Hughes
,
Douglas P. Dyer
,
Angela Simpson
,
Lee M. Booty
,
Maria Feeney
,
Peter C. Cook
,
Andrew S. MacDonald
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fimmu.2025.1654717
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fimmu.2025.1654717
Introduction Although human lung macrophages are heterogenous and play key roles during health and disease, the mechanisms that govern their activation and function are unclear, particularly in type 2 settings. Our understanding of how human lung macrophages respond to inflammatory signals have predominantly relied on cell lines or peripheral blood derived cells, which have a limited capacity to reflect the complexity of tissue macrophage responses. Methods We isolated macrophages from resected human lung tissue and stimulated them ex vivo under type 2 (IL-4, IL-13, or IL-4 + IL-13) or type 1 (IFNγ + LPS) conditions. Results Human lung macrophages stimulated with IL-4/13, alone or in combination, significantly upregulated expression of the chemokines CCL17, CCL18 and CCL22, along with the transglutaminase TGM2 and the lipoxygenase ALOX15. This type 2 activation profile was distinct from LPS + IFNγ activated human lung macrophages, which upregulated IL6, IL8, IL1B, TNFα and CHI3L1 (YKL-40). Further, type 2 activated human lung macrophage products showed differential metabolic reliance for their induction, with IL-4/13 induced CCL22 being glycolytically controlled, while ALOX15 was regulated by fatty acid oxidation. Discussion These data clarify hallmarks of human lung macrophage activation and polarisation in addition to revealing novel metabolic regulation of type 2 markers.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3389/fimmu.2025.1654717
- https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1654717/pdf
- OA Status
- gold
- References
- 78
- OpenAlex ID
- https://openalex.org/W4415097805
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415097805Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fimmu.2025.1654717Digital Object Identifier
- Title
-
The chemokines CCL22 and CCL17 are a defining feature of type 2 stimulated human lung macrophages and exhibit different metabolic dependenciesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-13Full publication date if available
- Authors
-
Amanda J. L. Ridley, Annabel J. Curle, Stefano A. P. Colombo, Jane Hughes, Douglas P. Dyer, Angela Simpson, Lee M. Booty, Maria Feeney, Peter C. Cook, Andrew S. MacDonaldList of authors in order
- Landing page
-
https://doi.org/10.3389/fimmu.2025.1654717Publisher landing page
- PDF URL
-
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1654717/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1654717/pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
78Number of works referenced by this work
Full payload
| id | https://openalex.org/W4415097805 |
|---|---|
| doi | https://doi.org/10.3389/fimmu.2025.1654717 |
| ids.doi | https://doi.org/10.3389/fimmu.2025.1654717 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41159038 |
| ids.openalex | https://openalex.org/W4415097805 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000378 |
| mesh[1].descriptor_ui | D054414 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | metabolism |
| mesh[1].descriptor_name | Chemokine CCL17 |
| mesh[2].qualifier_ui | Q000276 |
| mesh[2].descriptor_ui | D054414 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | immunology |
| mesh[2].descriptor_name | Chemokine CCL17 |
| mesh[3].qualifier_ui | Q000378 |
| mesh[3].descriptor_ui | D054422 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | metabolism |
| mesh[3].descriptor_name | Chemokine CCL22 |
| mesh[4].qualifier_ui | Q000276 |
| mesh[4].descriptor_ui | D054422 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | immunology |
| mesh[4].descriptor_name | Chemokine CCL22 |
| mesh[5].qualifier_ui | Q000276 |
| mesh[5].descriptor_ui | D008262 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | immunology |
| mesh[5].descriptor_name | Macrophage Activation |
| mesh[6].qualifier_ui | Q000276 |
| mesh[6].descriptor_ui | D016676 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | immunology |
| mesh[6].descriptor_name | Macrophages, Alveolar |
| mesh[7].qualifier_ui | Q000378 |
| mesh[7].descriptor_ui | D016676 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | metabolism |
| mesh[7].descriptor_name | Macrophages, Alveolar |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D015847 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Interleukin-4 |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D002478 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Cells, Cultured |
| mesh[10].qualifier_ui | Q000378 |
| mesh[10].descriptor_ui | D016207 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | metabolism |
| mesh[10].descriptor_name | Cytokines |
| mesh[11].qualifier_ui | Q000276 |
| mesh[11].descriptor_ui | D008168 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | immunology |
| mesh[11].descriptor_name | Lung |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | Q000378 |
| mesh[13].descriptor_ui | D054414 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | metabolism |
| mesh[13].descriptor_name | Chemokine CCL17 |
| mesh[14].qualifier_ui | Q000276 |
| mesh[14].descriptor_ui | D054414 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | immunology |
| mesh[14].descriptor_name | Chemokine CCL17 |
| mesh[15].qualifier_ui | Q000378 |
| mesh[15].descriptor_ui | D054422 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | metabolism |
| mesh[15].descriptor_name | Chemokine CCL22 |
| mesh[16].qualifier_ui | Q000276 |
| mesh[16].descriptor_ui | D054422 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | immunology |
| mesh[16].descriptor_name | Chemokine CCL22 |
| mesh[17].qualifier_ui | Q000276 |
| mesh[17].descriptor_ui | D008262 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | immunology |
| mesh[17].descriptor_name | Macrophage Activation |
| mesh[18].qualifier_ui | Q000276 |
| mesh[18].descriptor_ui | D016676 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | immunology |
| mesh[18].descriptor_name | Macrophages, Alveolar |
| mesh[19].qualifier_ui | Q000378 |
| mesh[19].descriptor_ui | D016676 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | metabolism |
| mesh[19].descriptor_name | Macrophages, Alveolar |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D015847 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Interleukin-4 |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D002478 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Cells, Cultured |
| mesh[22].qualifier_ui | Q000378 |
| mesh[22].descriptor_ui | D016207 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | metabolism |
| mesh[22].descriptor_name | Cytokines |
| mesh[23].qualifier_ui | Q000276 |
| mesh[23].descriptor_ui | D008168 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | immunology |
| mesh[23].descriptor_name | Lung |
| type | article |
| title | The chemokines CCL22 and CCL17 are a defining feature of type 2 stimulated human lung macrophages and exhibit different metabolic dependencies |
| biblio.issue | |
| biblio.volume | 16 |
| biblio.last_page | 1654717 |
| biblio.first_page | 1654717 |
| topics[0].id | https://openalex.org/T11313 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9991000294685364 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Immune cells in cancer |
| topics[1].id | https://openalex.org/T11532 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9988999962806702 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Chemokine receptors and signaling |
| topics[2].id | https://openalex.org/T11503 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9937000274658203 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cytokine Signaling Pathways and Interactions |
| is_xpac | False |
| apc_list.value | 2950 |
| apc_list.currency | USD |
| apc_list.value_usd | 2950 |
| apc_paid.value | 2950 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2950 |
| language | en |
| locations[0].id | doi:10.3389/fimmu.2025.1654717 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2595292759 |
| locations[0].source.issn | 1664-3224 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1664-3224 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Immunology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_lineage_names | Frontiers Media |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1654717/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Immunology |
| locations[0].landing_page_url | https://doi.org/10.3389/fimmu.2025.1654717 |
| locations[1].id | pmid:41159038 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in immunology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41159038 |
| locations[2].id | pmh:oai:doaj.org/article:c6baf938eff445af9daeee84a3582c39 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Frontiers in Immunology, Vol 16 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/c6baf938eff445af9daeee84a3582c39 |
| locations[3].id | pmh:oai:europepmc.org:11362160 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12554769 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5015918523 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7626-481X |
| authorships[0].author.display_name | Amanda J. L. Ridley |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I28407311 |
| authorships[0].affiliations[0].raw_affiliation_string | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[0].institutions[0].id | https://openalex.org/I28407311 |
| authorships[0].institutions[0].ror | https://ror.org/027m9bs27 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I28407311 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | University of Manchester |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Amanda J. L. Ridley |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[1].author.id | https://openalex.org/A5067137350 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-9105-1131 |
| authorships[1].author.display_name | Annabel J. Curle |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I28407311 |
| authorships[1].affiliations[0].raw_affiliation_string | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[1].institutions[0].id | https://openalex.org/I28407311 |
| authorships[1].institutions[0].ror | https://ror.org/027m9bs27 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I28407311 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | University of Manchester |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Annabel J. Curle |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[2].author.id | https://openalex.org/A5090471775 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3346-3437 |
| authorships[2].author.display_name | Stefano A. P. Colombo |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I28407311 |
| authorships[2].affiliations[0].raw_affiliation_string | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[2].institutions[0].id | https://openalex.org/I28407311 |
| authorships[2].institutions[0].ror | https://ror.org/027m9bs27 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I28407311 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | University of Manchester |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Stefano A. P. Colombo |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[3].author.id | https://openalex.org/A5075173453 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1389-3402 |
| authorships[3].author.display_name | Jane Hughes |
| authorships[3].countries | GB |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I28407311 |
| authorships[3].affiliations[0].raw_affiliation_string | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[3].institutions[0].id | https://openalex.org/I28407311 |
| authorships[3].institutions[0].ror | https://ror.org/027m9bs27 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I28407311 |
| authorships[3].institutions[0].country_code | GB |
| authorships[3].institutions[0].display_name | University of Manchester |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Joshua J. Hughes |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[4].author.id | https://openalex.org/A5036901624 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-5567-6241 |
| authorships[4].author.display_name | Douglas P. Dyer |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2800776015 |
| authorships[4].affiliations[0].raw_affiliation_string | Wellcome Centre for Cell-Matrix Research, Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I2799725268, https://openalex.org/I28407311 |
| authorships[4].affiliations[1].raw_affiliation_string | Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester, United Kingdom |
| authorships[4].institutions[0].id | https://openalex.org/I2799725268 |
| authorships[4].institutions[0].ror | https://ror.org/04rrkhs81 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2799725268 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | Manchester Academic Health Science Centre |
| authorships[4].institutions[1].id | https://openalex.org/I28407311 |
| authorships[4].institutions[1].ror | https://ror.org/027m9bs27 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I28407311 |
| authorships[4].institutions[1].country_code | GB |
| authorships[4].institutions[1].display_name | University of Manchester |
| authorships[4].institutions[2].id | https://openalex.org/I2800776015 |
| authorships[4].institutions[2].ror | https://ror.org/0094tm228 |
| authorships[4].institutions[2].type | facility |
| authorships[4].institutions[2].lineage | https://openalex.org/I2800776015, https://openalex.org/I28407311, https://openalex.org/I87048295 |
| authorships[4].institutions[2].country_code | GB |
| authorships[4].institutions[2].display_name | Wellcome Centre for Cell-Matrix Research |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Douglas P. Dyer |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester, United Kingdom, Wellcome Centre for Cell-Matrix Research, Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom |
| authorships[5].author.id | https://openalex.org/A5006644007 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-2733-6666 |
| authorships[5].author.display_name | Angela Simpson |
| authorships[5].countries | GB |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I28407311 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Immunology, Immunity to Infection and Respiratory Medicine Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[5].institutions[0].id | https://openalex.org/I28407311 |
| authorships[5].institutions[0].ror | https://ror.org/027m9bs27 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I28407311 |
| authorships[5].institutions[0].country_code | GB |
| authorships[5].institutions[0].display_name | University of Manchester |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Angela Simpson |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Immunology, Immunity to Infection and Respiratory Medicine Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[6].author.id | https://openalex.org/A5088366330 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-3003-5872 |
| authorships[6].author.display_name | Lee M. Booty |
| authorships[6].countries | AU |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I196021976 |
| authorships[6].affiliations[0].raw_affiliation_string | The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia |
| authorships[6].institutions[0].id | https://openalex.org/I196021976 |
| authorships[6].institutions[0].ror | https://ror.org/01b6kha49 |
| authorships[6].institutions[0].type | nonprofit |
| authorships[6].institutions[0].lineage | https://openalex.org/I196021976 |
| authorships[6].institutions[0].country_code | AU |
| authorships[6].institutions[0].display_name | Walter and Eliza Hall Institute of Medical Research |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Lee M. Booty |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia |
| authorships[7].author.id | https://openalex.org/A5038336047 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Maria Feeney |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I188950975 |
| authorships[7].affiliations[0].raw_affiliation_string | GlaxoSmithKline, Stevenage, United Kingdom |
| authorships[7].institutions[0].id | https://openalex.org/I188950975 |
| authorships[7].institutions[0].ror | https://ror.org/01xsqw823 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I188950975 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | GlaxoSmithKline (United Kingdom) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Maria Feeney |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | GlaxoSmithKline, Stevenage, United Kingdom |
| authorships[8].author.id | https://openalex.org/A5002729875 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-5208-4985 |
| authorships[8].author.display_name | Peter C. Cook |
| authorships[8].countries | GB |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I28407311 |
| authorships[8].affiliations[0].raw_affiliation_string | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I23923803, https://openalex.org/I90344618 |
| authorships[8].affiliations[1].raw_affiliation_string | Medical Research Council Centre for Medical Mycology at the University of Exeter, Faculty of Health and Life Sciences, Exeter, United Kingdom |
| authorships[8].institutions[0].id | https://openalex.org/I90344618 |
| authorships[8].institutions[0].ror | https://ror.org/03x94j517 |
| authorships[8].institutions[0].type | government |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210087105, https://openalex.org/I90344618 |
| authorships[8].institutions[0].country_code | GB |
| authorships[8].institutions[0].display_name | Medical Research Council |
| authorships[8].institutions[1].id | https://openalex.org/I23923803 |
| authorships[8].institutions[1].ror | https://ror.org/03yghzc09 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I23923803 |
| authorships[8].institutions[1].country_code | GB |
| authorships[8].institutions[1].display_name | University of Exeter |
| authorships[8].institutions[2].id | https://openalex.org/I28407311 |
| authorships[8].institutions[2].ror | https://ror.org/027m9bs27 |
| authorships[8].institutions[2].type | education |
| authorships[8].institutions[2].lineage | https://openalex.org/I28407311 |
| authorships[8].institutions[2].country_code | GB |
| authorships[8].institutions[2].display_name | University of Manchester |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Peter C. Cook |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, Medical Research Council Centre for Medical Mycology at the University of Exeter, Faculty of Health and Life Sciences, Exeter, United Kingdom |
| authorships[9].author.id | https://openalex.org/A5102138805 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Andrew S. MacDonald |
| authorships[9].countries | GB |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I98677209 |
| authorships[9].affiliations[0].raw_affiliation_string | Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I28407311 |
| authorships[9].affiliations[1].raw_affiliation_string | Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| authorships[9].institutions[0].id | https://openalex.org/I98677209 |
| authorships[9].institutions[0].ror | https://ror.org/01nrxwf90 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I98677209 |
| authorships[9].institutions[0].country_code | GB |
| authorships[9].institutions[0].display_name | University of Edinburgh |
| authorships[9].institutions[1].id | https://openalex.org/I28407311 |
| authorships[9].institutions[1].ror | https://ror.org/027m9bs27 |
| authorships[9].institutions[1].type | education |
| authorships[9].institutions[1].lineage | https://openalex.org/I28407311 |
| authorships[9].institutions[1].country_code | GB |
| authorships[9].institutions[1].display_name | University of Manchester |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Andrew S. MacDonald |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom, Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1654717/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-13T00:00:00 |
| display_name | The chemokines CCL22 and CCL17 are a defining feature of type 2 stimulated human lung macrophages and exhibit different metabolic dependencies |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11313 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9991000294685364 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Immune cells in cancer |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3389/fimmu.2025.1654717 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2595292759 |
| best_oa_location.source.issn | 1664-3224 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1664-3224 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Immunology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_lineage_names | Frontiers Media |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1654717/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Immunology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fimmu.2025.1654717 |
| primary_location.id | doi:10.3389/fimmu.2025.1654717 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2595292759 |
| primary_location.source.issn | 1664-3224 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1664-3224 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Immunology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_lineage_names | Frontiers Media |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1654717/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Immunology |
| primary_location.landing_page_url | https://doi.org/10.3389/fimmu.2025.1654717 |
| publication_date | 2025-10-13 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4205659783, https://openalex.org/W4223535139, https://openalex.org/W4372197328, https://openalex.org/W2416512496, https://openalex.org/W2623235591, https://openalex.org/W2604693432, https://openalex.org/W2887965556, https://openalex.org/W3036970560, https://openalex.org/W2017357618, https://openalex.org/W2530726117, https://openalex.org/W2915406286, https://openalex.org/W2998872970, https://openalex.org/W3097721739, https://openalex.org/W3005321388, https://openalex.org/W4220652963, https://openalex.org/W1841551052, https://openalex.org/W1667820694, https://openalex.org/W1919579956, https://openalex.org/W1610219140, https://openalex.org/W3091409330, https://openalex.org/W1984719956, https://openalex.org/W1813524205, https://openalex.org/W2155158870, https://openalex.org/W2997406734, https://openalex.org/W3003675501, https://openalex.org/W2806376977, https://openalex.org/W1878686232, https://openalex.org/W4221097653, https://openalex.org/W4388569149, https://openalex.org/W4308038057, https://openalex.org/W2150792294, https://openalex.org/W2160882555, https://openalex.org/W2088251776, https://openalex.org/W2091259355, https://openalex.org/W2094659815, https://openalex.org/W2290932679, https://openalex.org/W1996166546, https://openalex.org/W1974589759, https://openalex.org/W1720186552, https://openalex.org/W2038610464, https://openalex.org/W1986991315, https://openalex.org/W1976905332, https://openalex.org/W2078873071, https://openalex.org/W2086411755, https://openalex.org/W2103384599, https://openalex.org/W2147307055, https://openalex.org/W1548123291, https://openalex.org/W2076272449, https://openalex.org/W2309763940, https://openalex.org/W2135272175, https://openalex.org/W1926352629, https://openalex.org/W2287265171, https://openalex.org/W1989090840, https://openalex.org/W1585095351, https://openalex.org/W2142082641, https://openalex.org/W2145598816, https://openalex.org/W2716853262, https://openalex.org/W3107130704, https://openalex.org/W2089532303, https://openalex.org/W2971243228, https://openalex.org/W2153586956, https://openalex.org/W2801288105, https://openalex.org/W2810749981, https://openalex.org/W2927199411, https://openalex.org/W2617671967, https://openalex.org/W3034733248, https://openalex.org/W2063064466, https://openalex.org/W3108924494, https://openalex.org/W4399851281, https://openalex.org/W2945556908, https://openalex.org/W2991249454, https://openalex.org/W3003605792, https://openalex.org/W2921168633, https://openalex.org/W2971754877, https://openalex.org/W4285091948, https://openalex.org/W2999462941, https://openalex.org/W4295745405, https://openalex.org/W1565459643 |
| referenced_works_count | 78 |
| abstract_inverted_index.+ | 86, 92, 134 |
| abstract_inverted_index.1 | 90 |
| abstract_inverted_index.2 | 28, 81, 127, 151, 200 |
| abstract_inverted_index.a | 54 |
| abstract_inverted_index.We | 66 |
| abstract_inverted_index.by | 175 |
| abstract_inverted_index.ex | 77 |
| abstract_inverted_index.in | 26, 104, 191 |
| abstract_inverted_index.of | 32, 61, 109, 184, 198 |
| abstract_inverted_index.on | 44 |
| abstract_inverted_index.or | 47, 84, 88, 103 |
| abstract_inverted_index.to | 38, 57, 193 |
| abstract_inverted_index.LPS | 133 |
| abstract_inverted_index.Our | 30 |
| abstract_inverted_index.and | 7, 13, 21, 74, 114, 121, 146, 189 |
| abstract_inverted_index.are | 5, 23 |
| abstract_inverted_index.for | 161 |
| abstract_inverted_index.how | 33 |
| abstract_inverted_index.key | 9 |
| abstract_inverted_index.the | 15, 59, 110, 118, 122 |
| abstract_inverted_index.was | 130, 173 |
| abstract_inverted_index.IL-4 | 85 |
| abstract_inverted_index.IL6, | 142 |
| abstract_inverted_index.IL8, | 143 |
| abstract_inverted_index.LPS) | 93 |
| abstract_inverted_index.TGM2 | 120 |
| abstract_inverted_index.This | 125 |
| abstract_inverted_index.acid | 177 |
| abstract_inverted_index.cell | 45 |
| abstract_inverted_index.data | 181 |
| abstract_inverted_index.from | 69, 132 |
| abstract_inverted_index.have | 41, 53 |
| abstract_inverted_index.lung | 3, 35, 72, 97, 138, 154, 186 |
| abstract_inverted_index.play | 8 |
| abstract_inverted_index.that | 17 |
| abstract_inverted_index.them | 76 |
| abstract_inverted_index.type | 27, 80, 89, 126, 150, 199 |
| abstract_inverted_index.vivo | 78 |
| abstract_inverted_index.with | 100, 117, 164 |
| abstract_inverted_index.CCL18 | 113 |
| abstract_inverted_index.CCL22 | 167 |
| abstract_inverted_index.Human | 96 |
| abstract_inverted_index.IFNγ | 135 |
| abstract_inverted_index.IL1B, | 144 |
| abstract_inverted_index.TNFα | 145 |
| abstract_inverted_index.These | 180 |
| abstract_inverted_index.alone | 102 |
| abstract_inverted_index.along | 116 |
| abstract_inverted_index.being | 168 |
| abstract_inverted_index.blood | 49 |
| abstract_inverted_index.fatty | 176 |
| abstract_inverted_index.human | 2, 34, 71, 137, 153, 185 |
| abstract_inverted_index.lines | 46 |
| abstract_inverted_index.novel | 195 |
| abstract_inverted_index.roles | 10 |
| abstract_inverted_index.their | 19, 162 |
| abstract_inverted_index.under | 79 |
| abstract_inverted_index.which | 52, 140 |
| abstract_inverted_index.while | 171 |
| abstract_inverted_index.(IFNγ | 91 |
| abstract_inverted_index.(IL-4, | 82 |
| abstract_inverted_index.ALOX15 | 172 |
| abstract_inverted_index.CCL17, | 112 |
| abstract_inverted_index.CCL22, | 115 |
| abstract_inverted_index.CHI3L1 | 147 |
| abstract_inverted_index.IL-13) | 87 |
| abstract_inverted_index.IL-13, | 83 |
| abstract_inverted_index.cells, | 51 |
| abstract_inverted_index.during | 11 |
| abstract_inverted_index.govern | 18 |
| abstract_inverted_index.health | 12 |
| abstract_inverted_index.relied | 43 |
| abstract_inverted_index.showed | 157 |
| abstract_inverted_index.tissue | 62, 73 |
| abstract_inverted_index.ALOX15. | 124 |
| abstract_inverted_index.IL-4/13 | 165 |
| abstract_inverted_index.Methods | 65 |
| abstract_inverted_index.Results | 95 |
| abstract_inverted_index.clarify | 182 |
| abstract_inverted_index.derived | 50 |
| abstract_inverted_index.induced | 166 |
| abstract_inverted_index.limited | 55 |
| abstract_inverted_index.profile | 129 |
| abstract_inverted_index.reflect | 58 |
| abstract_inverted_index.respond | 37 |
| abstract_inverted_index.signals | 40 |
| abstract_inverted_index.Although | 1 |
| abstract_inverted_index.Further, | 149 |
| abstract_inverted_index.IL-4/13, | 101 |
| abstract_inverted_index.addition | 192 |
| abstract_inverted_index.capacity | 56 |
| abstract_inverted_index.disease, | 14 |
| abstract_inverted_index.distinct | 131 |
| abstract_inverted_index.function | 22 |
| abstract_inverted_index.isolated | 67 |
| abstract_inverted_index.markers. | 201 |
| abstract_inverted_index.products | 156 |
| abstract_inverted_index.reliance | 160 |
| abstract_inverted_index.resected | 70 |
| abstract_inverted_index.unclear, | 24 |
| abstract_inverted_index.(YKL-40). | 148 |
| abstract_inverted_index.activated | 136, 152 |
| abstract_inverted_index.hallmarks | 183 |
| abstract_inverted_index.metabolic | 159, 196 |
| abstract_inverted_index.regulated | 174 |
| abstract_inverted_index.revealing | 194 |
| abstract_inverted_index.settings. | 29 |
| abstract_inverted_index.Discussion | 179 |
| abstract_inverted_index.activation | 20, 128, 188 |
| abstract_inverted_index.chemokines | 111 |
| abstract_inverted_index.complexity | 60 |
| abstract_inverted_index.expression | 108 |
| abstract_inverted_index.induction, | 163 |
| abstract_inverted_index.macrophage | 63, 155, 187 |
| abstract_inverted_index.mechanisms | 16 |
| abstract_inverted_index.oxidation. | 178 |
| abstract_inverted_index.peripheral | 48 |
| abstract_inverted_index.regulation | 197 |
| abstract_inverted_index.responses. | 64 |
| abstract_inverted_index.stimulated | 75, 99 |
| abstract_inverted_index.conditions. | 94 |
| abstract_inverted_index.controlled, | 170 |
| abstract_inverted_index.macrophages | 4, 36, 68, 98 |
| abstract_inverted_index.upregulated | 107, 141 |
| abstract_inverted_index.Introduction | 0 |
| abstract_inverted_index.combination, | 105 |
| abstract_inverted_index.differential | 158 |
| abstract_inverted_index.heterogenous | 6 |
| abstract_inverted_index.inflammatory | 39 |
| abstract_inverted_index.lipoxygenase | 123 |
| abstract_inverted_index.macrophages, | 139 |
| abstract_inverted_index.particularly | 25 |
| abstract_inverted_index.polarisation | 190 |
| abstract_inverted_index.predominantly | 42 |
| abstract_inverted_index.significantly | 106 |
| abstract_inverted_index.understanding | 31 |
| abstract_inverted_index.glycolytically | 169 |
| abstract_inverted_index.transglutaminase | 119 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5102138805 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 10 |
| corresponding_institution_ids | https://openalex.org/I28407311, https://openalex.org/I98677209 |
| citation_normalized_percentile.value | 0.52723306 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |